Page last updated: 2024-09-04

docetaxel anhydrous and ginsenoside rg5

docetaxel anhydrous has been researched along with ginsenoside rg5 in 1 studies

Compound Research Comparison

Studies
(docetaxel anhydrous)
Trials
(docetaxel anhydrous)
Recent Studies (post-2010)
(docetaxel anhydrous)
Studies
(ginsenoside rg5)
Trials
(ginsenoside rg5)
Recent Studies (post-2010) (ginsenoside rg5)
12,1103,2166,92042042

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fan, D; Liu, Y1

Other Studies

1 other study(ies) available for docetaxel anhydrous and ginsenoside rg5

ArticleYear
Ginsenoside Rg5 induces apoptosis and autophagy via the inhibition of the PI3K/Akt pathway against breast cancer in a mouse model.
    Food & function, 2018, Nov-14, Volume: 9, Issue:11

    Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagy; Autophagy-Related Proteins; Breast Neoplasms; Disease Models, Animal; Docetaxel; Female; Gene Expression Regulation; Ginsenosides; Humans; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Panax; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Signal Transduction; Xenograft Model Antitumor Assays

2018
chemdatabank.com